Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Protection against TNFα-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNFα in vivo.

Lundberg P, Yang HJ, Jung SJ, Behlke MA, Rose SD, Cantin EM.

J Control Release. 2012 Jun 10;160(2):194-9. doi: 10.1016/j.jconrel.2011.10.034. Epub 2011 Nov 7.

2.

[CD38 protein reduces LPS/D-galactosamine-induced acute damage of liver tissues via down-regulating inflammatory cytokine expressions].

Wu Y, Liang L, Shi G.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Oct;30(10):1009-12. Chinese.

PMID:
25270198
3.

Dicer-substrate siRNA inhibits tumor necrosis factor alpha secretion in Kupffer cells in vitro: in vivo targeting of Kupffer cells by siRNA-liposomes.

Pichu S, Krishnamoorthy S, Zhang B, Jing Y, Shishkov A, Ponnappa BC.

Pharmacol Res. 2012 Jan;65(1):48-55. doi: 10.1016/j.phrs.2011.09.001. Epub 2011 Sep 10.

4.

Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.

Endo Y, Shibazaki M, Yamaguchi K, Kai K, Sugawara S, Takada H, Kikuchi H, Kumagai K.

Br J Pharmacol. 1999 Sep;128(1):5-12.

5.

Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.

Zhou J, Neff CP, Liu X, Zhang J, Li H, Smith DD, Swiderski P, Aboellail T, Huang Y, Du Q, Liang Z, Peng L, Akkina R, Rossi JJ.

Mol Ther. 2011 Dec;19(12):2228-38. doi: 10.1038/mt.2011.207. Epub 2011 Sep 27.

6.

Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.

Xie C, Jingjing W, Li X, Zeng F, Ma L, Li C, Wei Z, Peng A, Chen L.

Int Immunopharmacol. 2014 Aug;21(2):261-8. doi: 10.1016/j.intimp.2014.05.012. Epub 2014 May 24.

PMID:
24861250
7.

Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.

Khoury M, Louis-Plence P, Escriou V, Noel D, Largeau C, Cantos C, Scherman D, Jorgensen C, Apparailly F.

Arthritis Rheum. 2006 Jun;54(6):1867-77.

8.

Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages.

Avni D, Goldsmith M, Ernst O, Mashiach R, Tuntland T, Meijler MM, Gray NS, Rosen H, Zor T.

Immunol Lett. 2009 Mar 24;123(1):1-8. doi: 10.1016/j.imlet.2008.12.011. Epub 2009 Jan 29.

PMID:
19185589
9.

Reduced PMA enhances the responsiveness of transfected THP-1 macrophages to polarizing stimuli.

Maeß MB, Wittig B, Cignarella A, Lorkowski S.

J Immunol Methods. 2014 Jan 15;402(1-2):76-81. doi: 10.1016/j.jim.2013.11.006. Epub 2013 Nov 21.

PMID:
24269601
10.

The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury.

Pathil A, Warth A, Chamulitrat W, Stremmel W.

J Hepatol. 2011 Apr;54(4):674-84. doi: 10.1016/j.jhep.2010.07.028. Epub 2010 Sep 27.

PMID:
21146893
11.

Functionally enhanced siRNA targeting TNFα attenuates DSS-induced colitis and TLR-mediated immunostimulation in mice.

Ocampo SM, Romero C, Aviñó A, Burgueño J, Gassull MA, Bermúdez J, Eritja R, Fernandez E, Perales JC.

Mol Ther. 2012 Feb;20(2):382-90. doi: 10.1038/mt.2011.236. Epub 2011 Nov 1.

12.

Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.

Banskota AH, Nguyen NT, Tezuka Y, Le Tran Q, Nobukawa T, Kurashige Y, Sasahara M, Kadota S.

Life Sci. 2004 Apr 16;74(22):2781-92.

PMID:
15043992
13.

Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model.

Choi B, Hwang Y, Kwon HJ, Lee ES, Park KS, Bang D, Lee S, Sohn S.

J Dermatol Sci. 2008 Nov;52(2):87-97. doi: 10.1016/j.jdermsci.2008.05.001. Epub 2008 Jun 27.

PMID:
18585901
14.

Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation.

Li X, Gou C, Yang H, Qiu J, Gu T, Wen T.

Scand J Gastroenterol. 2014 Aug;49(8):993-1000. doi: 10.3109/00365521.2014.913190. Epub 2014 May 5.

PMID:
24797709
15.

Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease.

Bala S, Marcos M, Kodys K, Csak T, Catalano D, Mandrekar P, Szabo G.

J Biol Chem. 2011 Jan 14;286(2):1436-44. doi: 10.1074/jbc.M110.145870. Epub 2010 Nov 9.

16.

Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice.

Ambade A, Catalano D, Lim A, Mandrekar P.

Hepatology. 2012 May;55(5):1585-95. doi: 10.1002/hep.24802. Epub 2012 Mar 18.

17.

Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.

Wan JY, Gong X, Zhang L, Li HZ, Zhou YF, Zhou QX.

Eur J Pharmacol. 2008 Jun 10;587(1-3):302-8. doi: 10.1016/j.ejphar.2008.02.081. Epub 2008 Mar 7.

PMID:
18420187
18.

Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitis.

Fukuda T, Mogami A, Tanaka H, Yoshikawa T, Hisadome M, Komatsu H.

Life Sci. 2006 Jul 24;79(9):822-7. Epub 2006 Mar 28.

PMID:
16626762
19.

Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.

Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP.

Nature. 2009 Apr 30;458(7242):1180-4. doi: 10.1038/nature07774.

20.

Anti-tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C.

Brenndörfer ED, Weiland M, Frelin L, Derk E, Ahlén G, Jiao J, Bode JG, Sällberg M.

Hepatology. 2010 Nov;52(5):1553-63. doi: 10.1002/hep.23870.

PMID:
20886569

Supplemental Content

Support Center